nitroaspirin has been researched along with Atherogenesis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolla, M; Daemen, MJ; Gijbels, MJ; Heeneman, S; Hoving, S; Pol, JF; Russell, NS; Simons, MY; Stewart, FA; te Poele, JA | 1 |
Arosio, E; Bonizzoni, E; Gresele, P; Migliacci, R; Minuz, P; Violi, F | 1 |
Parthasarathy, S; Santanam, N | 1 |
Gresele, P; Momi, S | 1 |
1 review(s) available for nitroaspirin and Atherogenesis
Article | Year |
---|---|
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
Topics: Animals; Aspirin; Atherosclerosis; Endothelium, Vascular; Humans; Molecular Structure; Myocardial Ischemia; Nitric Oxide Donors; Platelet Aggregation Inhibitors; Treatment Outcome | 2006 |
1 trial(s) available for nitroaspirin and Atherogenesis
Article | Year |
---|---|
Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication.
Topics: Aged; Aspirin; Atherosclerosis; Carotid Intima-Media Thickness; Double-Blind Method; Drug Administration Schedule; Exercise Test; Exercise Tolerance; Female; Fibrinolytic Agents; Humans; Intermittent Claudication; Male; Middle Aged; Nitric Oxide Donors; Prospective Studies; Walking | 2012 |
2 other study(ies) available for nitroaspirin and Atherogenesis
Article | Year |
---|---|
NO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice.
Topics: Age Factors; Animals; Apolipoproteins E; Aspirin; Atherosclerosis; Carotid Arteries; Disease Models, Animal; Down-Regulation; Female; Gene Expression; Humans; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation; Vascular Cell Adhesion Molecule-1; X-Rays | 2010 |
Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis.
Topics: Adult; Antioxidants; Aryldialkylphosphatase; Aspirin; Atherosclerosis; Binding, Competitive; Biotransformation; Humans; Hydrolysis; In Vitro Techniques; Nitrophenols; Paraoxon; Platelet Aggregation Inhibitors; Salicylic Acid | 2007 |